Tag

Last week, the Internet blew up over the greed of pharma companies and the cost of life-improving and life-saving medicines.

Clinton made the company and the price hike exhibit A in the case for her drug plan, and she made its CEO the poster child of pharma executives run amok.

It’ll be interesting to see how long this attention lasts.

Sen. Bernie Sanders, a Democratic presidential candidate from Vermont, and Rep. Elijah Cummings of Maryland, have asked Shkreli and Turing to reconsider their actions.

“And with these new profits we can spend all of that upside on these patients who sorely need a new drug, in my opinion”, Shkreli continued.

According to the executive, since Turing Pharmaceuticals is now the owner of Daraprim, it is his job to ensure the financial stability of the company.

In an unrelated incident, Turing Pharmaceuticals announced plans to raise the price of pyrimethamine (Daraprim) by more than 4000%.

Shkreli told TV networks that his company has agreed to lower the price of the drug, Daraprim – but he didn’t specify what the new price would be.

Martin Shkreli, a former hedge fund manager who is now chief executive officer of Turing Pharmaceuticals AG, was called out by Democratic presidential candidate Hillary Clinton.

But the price hike sparked outrage from medical groups representing doctors who care for patients with HIV and other infectious diseases, because Daraprim treats patients with compromised immune systems.